tirzepatide surpass-4 Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial Effects of tirzepatide versus insulin

SURMOUNT-1 results by dose The landmark SURMOUNT-1 trial enrolled 2,539 adults with obesity or overweight (BMI of 30 or higher, or 27 or higher with at least one weight-related complication)

Always follow your doctors instructions and never guess the dose

Do not use tirzepatide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

This is why many people struggle to lose abdominal fat even with a consistent diet and exercise

When Zepbound is taken with other prescription drugs, over-the-counter medications, vitamins, herbal products, and supplements, it may change how they work or increase the risk of side effects

This is what allows you to draw from the same vial multiple times over weeks